Br-C10-methyl ester

CAS No. 6287-90-7

Br-C10-methyl ester ( —— )

Catalog No. M26930 CAS No. 6287-90-7

Br-C10-methyl ester is a PROTAC linker, which refers to the alkyl/ether composition. Br-C10-methyl ester is used in the synthesis of a series of PROTACs (MS432).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 50 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Br-C10-methyl ester
  • Note
    Research use only, not for human use.
  • Brief Description
    Br-C10-methyl ester is a PROTAC linker, which refers to the alkyl/ether composition. Br-C10-methyl ester is used in the synthesis of a series of PROTACs (MS432).
  • Description
    Br-C10-methyl ester is a PROTAC linker, which refers to the alkyl/ether composition. Br-C10-methyl ester is used in the synthesis of a series of PROTACs (MS432).
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    JNK; MMP-9; p38
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6287-90-7
  • Formula Weight
    279.2
  • Molecular Formula
    C12H23BrO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC(=O)CCCCCCCCCCBr
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lucidenic acids-rich extract from antlered form of Ganoderma lucidum enhances TNFα± induction in THP-1 monocytic cells possibly via its modulation of MAP kinases p38 and JNK.Biochem Biophys Res Commun. 2011 Apr 29;408(1):18-24.
molnova catalog
related products
  • Cyclosporin H

    Cyclosporin H (CsH), a specific inhibitor of FPR1, inhibited lung inflammation in the ALI models.

  • CJ-42794

    CJ-42794 is a selective antagonist of prostaglandin E receptor subtype 4 (EP4). It inhibits [3H]-PGE2 binding to the human EP4 receptor (a mean pKi: 8.5).

  • Alisol B 23-acetate

    Alisol B 23-acetate produces protective effect against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes.